Neuronoff, Inc.
Neuronoff, Inc. is developing new medical devices utilizing neuromodulation to restore & improve organ activity in the human body. The primary focus is on treatments for chronic pain.
Neuronoff, Inc.
Neuronoff is a medical device company specializing in minimally invasive neuromodulation solutions for chronic pain management and other conditions using their Injectrode technology.
About
Needs Assessment
Active buying signals and potential business opportunities
Technology Requirements
Minimally invasive neuromodulation solutions
External pulse generator (EPG)
Needle-based delivery platforms
Self-anchoring leads
Helical wire structure
Transforaminal Injection System
Service Requirements
Training on Injectrode placement and removal procedures
Support for device maintenance
Consulting for regulatory strategy and clinical affairs
Infrastructure Requirements
Ultrasound equipment
Fluoroscopy equipment
MRI equipment
cGMP manufacturing facilities
Scalable server infrastructure and CDN services
Talent Requirements
Engineers with experience in medical device development
Regulatory affairs specialists
Clinical trial managers
Manufacturing specialists
Experts in neuromodulation and pain management
AI Insights
Growth Trajectory
Neuronoff demonstrates strong growth potential through ongoing clinical trials, planned product development, and expansion into new therapeutic areas, signaling a strategic push for market penetration.
Market Opportunity
Neuronoff has a significant market opportunity by providing a less invasive and more accessible neuromodulation solution, positioning them to capture a larger share of the chronic pain treatment market.
Access Our Live VC Funding Database
30,000+ funded startups
tracked in the last 3 months
B2B verified emails
of key decision makers
Growth metrics
Real-time company performance data
Live updates
of new VC funding rounds
Advanced filters
for sophisticated queries
API access
with multiple export formats